Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2022 | An overview of the pathophysiology of PNH

Shreyans Gandhi • 31 Mar 2022
BSH 2022
Aplastic Anemia Non-Malignant Paroxysmal Nocturnal Hemoglobinuria

Shreyans Gandhi, MBBS, MD, DNB(Internal Medicine), MRCP, FRCPath, M.Phil, King’s College Hospital NHS Foundation Trust, London, UK, gives an overview of his presentation at BSH 2022, which focused on the pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH). Dr Gandhi briefly explains what was covered in this presentation, including how PNH clones emerge and affect patients with aplastic anemia, and how the complement system plays an important role in the development of disease, as well as the discovery of numerous therapeutic agents. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.

More from Shreyans Gandhi

1:47
The need for new diagnostic criteria in VOD
Shreyans Gandhi • 31 Mar 2022
1:41
A look at the future treatment landscape of PNH
Shreyans Gandhi • 31 Mar 2022

Related Videos

2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals